SMAD6 correlated with poor patient survival among non-small cell lung cancer, and its knockdown inhibited cell proliferation and increased apoptosis in the lung cancer cell line (Jeon et al., 2008). This evidence concerns the gene SMAD6 and non-small cell lung carcinoma.